Hypersensitivity reactions to platinum-based compounds in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Description and management

Allergy. 2021 Jun;76(6):1882-1885. doi: 10.1111/all.14679. Epub 2020 Dec 22.

Authors

Amélie Gauthier^{1

2}, Farid Mankouri¹, Pascal Demoly^{1

3}, Olivia Sgarbura⁴, Anca Mirela Chiriac^{1

3}

Affiliations

¹ Division of Allergy, Department of Pulmonology, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Univ Montpellier, Montpellier, France.
² Department of Allergy and Immunology, Laval University Hospital Center, Laval University, Quebec City, QC, Canada.
³ UMR-S 1136, INSERM-Sorbonne Université, Equipe EPAR-IPLESP, Paris, France.
⁴ Department of Surgical Oncology, Cancer Institute of Montpellier, Montpellier, France.

PMID: 33616981
DOI: 10.1111/all.14679

No abstract available

Publication types

Letter

MeSH terms

Aerosols
Humans
Organoplatinum Compounds*
Oxaliplatin
Platinum Compounds*

Substances

Aerosols
Organoplatinum Compounds
Platinum Compounds
Oxaliplatin